IE920267A1 - Compounds - Google Patents
CompoundsInfo
- Publication number
- IE920267A1 IE920267A1 IE026792A IE920267A IE920267A1 IE 920267 A1 IE920267 A1 IE 920267A1 IE 026792 A IE026792 A IE 026792A IE 920267 A IE920267 A IE 920267A IE 920267 A1 IE920267 A1 IE 920267A1
- Authority
- IE
- Ireland
- Prior art keywords
- salt
- methylphenylamino
- butyryl
- quinoline
- salt according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919101919A GB9101919D0 (en) | 1991-01-29 | 1991-01-29 | Compound |
| GB919101918A GB9101918D0 (en) | 1991-01-29 | 1991-01-29 | Compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IE920267A1 true IE920267A1 (en) | 1992-07-29 |
Family
ID=26298350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE026792A IE920267A1 (en) | 1991-01-29 | 1992-01-28 | Compounds |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0569396A1 (fr) |
| JP (1) | JPH06504541A (fr) |
| CN (1) | CN1064268A (fr) |
| AP (1) | AP337A (fr) |
| AU (1) | AU652028B2 (fr) |
| CA (1) | CA2099117A1 (fr) |
| CZ (1) | CZ153293A3 (fr) |
| FI (1) | FI933376L (fr) |
| HU (1) | HUT67609A (fr) |
| IE (1) | IE920267A1 (fr) |
| IL (1) | IL100791A0 (fr) |
| MA (1) | MA22401A1 (fr) |
| MX (1) | MX9200338A (fr) |
| NO (1) | NO932722D0 (fr) |
| NZ (1) | NZ241408A (fr) |
| PT (1) | PT100056A (fr) |
| SK (1) | SK70993A3 (fr) |
| WO (1) | WO1992012969A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9126438D0 (en) * | 1991-12-12 | 1992-02-12 | Smithkline Beecham Intercredit | New quinoline derivatives |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| USRE43932E1 (en) | 1997-07-18 | 2013-01-15 | Novartis Ag | Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| US20050020637A1 (en) * | 2001-11-19 | 2005-01-27 | Wolfgang-Alexander Simon | Agents for the treatment of airway disorders |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| AU2003254282A1 (en) | 2002-08-01 | 2004-02-23 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
| WO2005041961A1 (fr) | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Procede d'utilisation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8804444D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
-
1992
- 1992-01-27 FI FI933376A patent/FI933376L/fi unknown
- 1992-01-27 CA CA002099117A patent/CA2099117A1/fr not_active Abandoned
- 1992-01-27 JP JP4503051A patent/JPH06504541A/ja active Pending
- 1992-01-27 HU HU9302201A patent/HUT67609A/hu unknown
- 1992-01-27 AP APAP/P/1992/000352A patent/AP337A/en active
- 1992-01-27 WO PCT/EP1992/000200 patent/WO1992012969A1/fr not_active Ceased
- 1992-01-27 NZ NZ241408A patent/NZ241408A/en unknown
- 1992-01-27 MA MA22687A patent/MA22401A1/fr unknown
- 1992-01-27 AU AU11799/92A patent/AU652028B2/en not_active Ceased
- 1992-01-27 EP EP92903019A patent/EP0569396A1/fr not_active Withdrawn
- 1992-01-27 MX MX9200338A patent/MX9200338A/es unknown
- 1992-01-27 SK SK709-93A patent/SK70993A3/sk unknown
- 1992-01-27 CZ CZ931532A patent/CZ153293A3/cs unknown
- 1992-01-28 IE IE026792A patent/IE920267A1/en unknown
- 1992-01-28 CN CN92101029A patent/CN1064268A/zh active Pending
- 1992-01-28 IL IL100791A patent/IL100791A0/xx unknown
- 1992-01-28 PT PT100056A patent/PT100056A/pt not_active Application Discontinuation
-
1993
- 1993-07-28 NO NO932722A patent/NO932722D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1179992A (en) | 1992-08-27 |
| SK70993A3 (en) | 1994-01-12 |
| EP0569396A1 (fr) | 1993-11-18 |
| NO932722L (no) | 1993-07-28 |
| IL100791A0 (en) | 1992-09-06 |
| AP9200352A0 (en) | 1992-01-31 |
| NO932722D0 (no) | 1993-07-28 |
| FI933376A7 (fi) | 1993-07-28 |
| NZ241408A (en) | 1994-05-26 |
| AU652028B2 (en) | 1994-08-11 |
| CZ153293A3 (en) | 1993-12-15 |
| CN1064268A (zh) | 1992-09-09 |
| MX9200338A (es) | 1992-12-01 |
| WO1992012969A1 (fr) | 1992-08-06 |
| MA22401A1 (fr) | 1992-10-01 |
| JPH06504541A (ja) | 1994-05-26 |
| FI933376A0 (fi) | 1993-07-28 |
| HU9302201D0 (en) | 1993-10-28 |
| HUT67609A (en) | 1995-04-28 |
| AP337A (en) | 1994-04-08 |
| FI933376L (fi) | 1993-07-28 |
| PT100056A (pt) | 1993-03-31 |
| CA2099117A1 (fr) | 1992-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100704152B1 (ko) | NF-κB 저해제를 유효 성분으로 하는 심근염, 확장형 심근증 및 심부전의 예방제 또는 치료제 | |
| AP337A (en) | Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. | |
| US5346897A (en) | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance | |
| JP2502343B2 (ja) | 薬学的に活性な置換ベンズアミド | |
| US3860647A (en) | {60 -Aminomethyl-4-hydroxy-3-sulfamyl-benzyl alcohols and 4-hydroxy-3-sulfamyl phenethylamines | |
| EP0351435B1 (fr) | Composes de pyridazine fusionnes et leurs utilisations medicales | |
| EP0104614B1 (fr) | Dérivés du phénylpipérazine et leur procédé de préparation | |
| EP3216791B1 (fr) | Substance polymorphe de chlorhydrate de yonkenafil, son procédé de préparation, composition à base de ladite substance et utilisation deladite substance | |
| WO2023221825A1 (fr) | Dérivé de sesquiterpène, composition pharmaceutique de celui-ci, procédé de préparation correspondant et utilisation associée | |
| EP1097924B1 (fr) | Dérivés de la 4-hydroxy-4-phenylpiperidine ayant une activité agoniste opioide et médicaments les contenant | |
| KR102465988B1 (ko) | 항암, 항염증 효능을 가진 삼원환의 약학적 조성물 | |
| JP2974351B2 (ja) | プロドラッグとしての6―クロロ―7,8―ジヒドロキシ―1―(4’―ヒドロキシフェニル)―2,3,4,5―テトラヒドロ―1h―3―ベンズアゼピンのカルバメート | |
| EP0146155B1 (fr) | Dérivé d'un éther de n-propanolamine | |
| JPH069402A (ja) | 抗潰瘍剤 | |
| WO1990004590A1 (fr) | Derives de benzothiadiazepine | |
| JPS6130588A (ja) | ベンゾ〔c〕〔1,8〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤 | |
| EP0461681B1 (fr) | Emploi de quinazolines dans la préparation d'un médicament pour le traitement et la prévention de l'arythmie | |
| CA1106389A (fr) | Obtention de derives d'acide 2-(phenylalkylhydrazono)- propionique | |
| US3155672A (en) | N-diphenylisomcotinamide | |
| AU1920895A (en) | Tricyclic spiropiperidines | |
| JPH01233284A (ja) | 新規縮合ジアゼピノン類、その製法及びこれらの化合物を含む医薬組成物 | |
| US4451468A (en) | Acidiferous 17-normal-pentyl sparteine tartaric and fumaric acid salts pharmaceutical compositions thereof | |
| JPS6342625B2 (fr) | ||
| JP2000038382A (ja) | 新規ベンゾフラノン誘導体及びその製造方法 | |
| HUT77949A (hu) | Kinolinszármazékok, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk |